These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Vascular endothelial growth factor stimulates dephosphorylation of the catenins p120 and p100 in endothelial cells. Wong EY; Morgan L; Smales C; Lang P; Gubby SE; Staddon JM Biochem J; 2000 Feb; 346 Pt 1(Pt 1):209-16. PubMed ID: 10657259 [TBL] [Abstract][Full Text] [Related]
6. Vasculogenesis, angiogenesis and the molecular organisation of endothelial junctions in the early human placenta. Leach L; Babawale MO; Anderson M; Lammiman M J Vasc Res; 2002; 39(3):246-59. PubMed ID: 12097823 [TBL] [Abstract][Full Text] [Related]
8. PEDF regulates vascular permeability by a γ-secretase-mediated pathway. Cai J; Wu L; Qi X; Li Calzi S; Caballero S; Shaw L; Ruan Q; Grant MB; Boulton ME PLoS One; 2011; 6(6):e21164. PubMed ID: 21695048 [TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor induces SHC association with vascular endothelial cadherin: a potential feedback mechanism to control vascular endothelial growth factor receptor-2 signaling. Zanetti A; Lampugnani MG; Balconi G; Breviario F; Corada M; Lanfrancone L; Dejana E Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):617-22. PubMed ID: 11950700 [TBL] [Abstract][Full Text] [Related]
10. Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148. Grazia Lampugnani M; Zanetti A; Corada M; Takahashi T; Balconi G; Breviario F; Orsenigo F; Cattelino A; Kemler R; Daniel TO; Dejana E J Cell Biol; 2003 May; 161(4):793-804. PubMed ID: 12771128 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis. Haspel HC; Scicli GM; McMahon G; Scicli AG Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation. Lin MT; Yen ML; Lin CY; Kuo ML Mol Pharmacol; 2003 Nov; 64(5):1029-36. PubMed ID: 14573751 [TBL] [Abstract][Full Text] [Related]
13. Down-modulation of monocyte transendothelial migration and endothelial adhesion molecule expression by fibroblast growth factor: reversal by the anti-angiogenic agent SU6668. Zhang H; Issekutz AC Am J Pathol; 2002 Jun; 160(6):2219-30. PubMed ID: 12057924 [TBL] [Abstract][Full Text] [Related]
14. ICAM-1-mediated, Src- and Pyk2-dependent vascular endothelial cadherin tyrosine phosphorylation is required for leukocyte transendothelial migration. Allingham MJ; van Buul JD; Burridge K J Immunol; 2007 Sep; 179(6):4053-64. PubMed ID: 17785844 [TBL] [Abstract][Full Text] [Related]
15. Tyrosine residues 951 and 1059 of vascular endothelial growth factor receptor-2 (KDR) are essential for vascular permeability factor/vascular endothelial growth factor-induced endothelium migration and proliferation, respectively. Zeng H; Sanyal S; Mukhopadhyay D J Biol Chem; 2001 Aug; 276(35):32714-9. PubMed ID: 11435426 [TBL] [Abstract][Full Text] [Related]